Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Common Equity (2019 - 2025)

Cellebrite DI (CLBT) has 6 years of Common Equity data on record, last reported at $484.3 million in Q4 2025.

  • For Q4 2025, Common Equity rose 44.13% year-over-year to $484.3 million; the TTM value through Dec 2025 reached $484.3 million, up 44.13%, while the annual FY2025 figure was $484.3 million, 44.13% up from the prior year.
  • Common Equity reached $484.3 million in Q4 2025 per CLBT's latest filing, up from $336.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $484.3 million in Q4 2025 and bottomed at -$73.3 million in Q4 2021.
  • Average Common Equity over 5 years is $171.0 million, with a median of $73.9 million recorded in 2022.
  • Peak YoY movement for Common Equity: crashed 214.96% in 2021, then surged 882.17% in 2024.
  • A 5-year view of Common Equity shows it stood at -$73.3 million in 2021, then skyrocketed by 200.71% to $73.9 million in 2022, then tumbled by 53.68% to $34.2 million in 2023, then soared by 882.17% to $336.0 million in 2024, then soared by 44.13% to $484.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $484.3 million in Q4 2025, $336.0 million in Q4 2024, and $34.2 million in Q4 2023.